As of Jan 20
| -0.14 / -0.79%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.00, with a high estimate of 22.00 and a low estimate of 20.00. The median estimate represents a +13.31% increase from the last price of 17.65.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.